A carregar...
My burning issues in neuroendocrine tumours (NET)
Several compounds have recently been approved for the systemic treatment of advanced well-differentiated neuroendocrine tumours (NET) of gastroenteropancreatic (GEP) or lung origin. Based on the PROMID and CLARINET trials, somatostatin analogues (SSA) are the preferred first-line approach for all GE...
Na minha lista:
| Publicado no: | Memo |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Vienna
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6280958/ https://ncbi.nlm.nih.gov/pubmed/30595757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-018-0449-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|